Form 4 Tracker
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA

67 insider filings · Latest: Aug 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 4, 2025Mar 4 11:44 PMHughes Eric A
Proposed Sale
23,251$16.00$372.0K

View →

Mar 4, 2025Mar 4 11:37 PMDaniell Richard
Proposed Sale
86,400$16.00$1.4M

View →

Mar 4, 2025Mar 4 11:30 PMFrancis Richard D
Proposed Sale
23,773$16.00$380.4K

View →

Mar 3, 2025Mar 3 6:14 PMFrancis Richard D
Proposed Sale
31,342$16.46$515.9K

View →

Mar 3, 2025Mar 3 6:07 PMHughes Eric A
Proposed Sale
24,900$16.46$409.9K

View →

Mar 3, 2025Mar 3 5:59 PMDaniell Richard
Proposed Sale
62,250$16.46$1.0M

View →

Feb 28, 2025Feb 28 4:52 PMKalif Eliyahu Sharon
Proposed Sale
55,750$16.21$903.5K

View →

Feb 18, 2025Feb 18 5:38 PMFrancis Richard D
Proposed Sale
75,506$16.95$1.3M

View →

Feb 12, 2025Feb 13 1:06 PMSabag Mark
Proposed Sale
177,626$16.25$2.9M

View →

Dec 20, 2024Dec 21 12:03 AMBridger Management, LLC (1)
Proposed Sale
286,000$21.31$6.1M

View →

Nov 20, 2024Nov 20 4:39 PMFox Christine
Proposed Sale
19,388$16.87$327.1K

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 27, 2026Jan 29 9:07 PMEliyahu Sharon KalifEVP, Chief Financial Officer
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:05 PMEric A HughesSee "Remarks"
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:04 PMMark SabagSee "Remarks"
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:02 PMRichard DaniellExec. VP, European Commercial
Grant/Award
141,478141,478(D)

View →

Jan 27, 2026Jan 29 9:01 PMRichard D FrancisPresident and CEO
Grant/Award
1,511,425891,315(D)

View →

← Previous

Page 4 of 4